M 
Meilleure Health International Industry Group 2327.HK · HKD
Industrials · HKEX · 🇭🇰 Hong Kong
0.17
0.00%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in HKD, from our data supplier.
Revenue
HK$36.5m
FY2016FY2025
Net income
HK$38.0m
FY2016FY2025
Free cash flow
−HK$50.6m
FY2016FY2025
Shareholders' equity
HK$1.25bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | HK$36.5m | HK$50.7m | HK$129.3m | HK$119.9m | HK$253.0m | HK$265.1m | HK$234.8m | HK$230.5m | HK$68.7m | HK$63.9m |
| Operating income | −HK$9.7m | −HK$3.9m | HK$39.4m | HK$32.2m | HK$53.3m | HK$60.3m | HK$6.2m | HK$120.4m | HK$12.3m | HK$5.0m |
| Net income | HK$38.0m | HK$32.5m | HK$40.8m | HK$17.8m | HK$60.3m | HK$83.4m | −HK$23.0m | HK$80.5m | HK$80.1m | HK$34.5m |
| Diluted earnings per share | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | -0.01 | 0.02 | 0.02 | 0.01 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | HK$1.82bn | HK$1.67bn | HK$1.70bn | HK$1.71bn | HK$1.74bn | HK$1.70bn | HK$1.71bn | HK$1.30bn | HK$1.07bn | HK$573.8m |
| Cash and short-term investments | HK$20.2m | HK$29.9m | HK$106.3m | HK$211.0m | HK$380.4m | HK$281.3m | HK$442.0m | HK$161.1m | HK$50.9m | HK$55.8m |
| Total liabilities | HK$567.3m | HK$467.3m | HK$442.9m | HK$384.2m | HK$306.3m | HK$299.6m | HK$448.2m | HK$475.0m | HK$387.0m | HK$228.0m |
| Debt | HK$381.3m | HK$303.1m | HK$297.1m | HK$249.1m | HK$170.4m | HK$154.8m | HK$329.4m | HK$369.9m | HK$272.1m | HK$187.7m |
| Shareholders' equity | HK$1.25bn | HK$1.20bn | HK$1.25bn | HK$1.32bn | HK$1.43bn | HK$1.40bn | HK$1.26bn | HK$817.0m | HK$682.4m | HK$559.3m |
| Shares outstanding | 4,063m | 4,070m | 4,094m | 4,094m | 4,180m | 4,272m | 4,272m | 3,839m | 3,533m | 2,948m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −HK$50.0m | HK$186.0m | −HK$136.5m | HK$43.2m | −HK$83.3m | HK$70.8m | HK$25.4m | HK$17.9m | −HK$68.0m | −HK$233.0m |
| Capital spending | −HK$583,000 | −HK$132,000 | −HK$827,000 | −HK$1.1m | −HK$6.5m | −HK$417,000 | −HK$139,000 | −HK$111,000 | −HK$3.7m | −HK$9,000 |
| Free cash flow | −HK$50.6m | HK$185.9m | −HK$137.3m | HK$42.1m | −HK$89.8m | HK$70.4m | HK$25.3m | HK$17.8m | −HK$71.7m | −HK$233.0m |
| Dividends paid | −HK$22.5m | −HK$16.4m | −HK$65.5m | — | — | — | — | — | −HK$20.3m | −HK$20.3m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | HK$4.7m | HK$4.7m | HK$19.1m | HK$4.7m | HK$17.5m | HK$20.6m | HK$30.0m | HK$54.5m |
| Operating income | HK$1.6m | HK$1.6m | −HK$10.6m | HK$1.6m | HK$907,000 | −HK$1.9m | −HK$496,000 | HK$18.9m |
| Net income | HK$990,500 | HK$990,500 | HK$22.8m | HK$990,500 | HK$15.2m | HK$24.0m | HK$8.5m | HK$22.7m |
| Diluted earnings per share | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Cash from operations | HK$1.0m | HK$1.0m | −HK$40.0m | HK$1.0m | −HK$5.0m | HK$74.0m | HK$113.0m | −HK$44.0m |
| Capital spending | −HK$1.0m | −HK$1.0m | — | −HK$1.0m | — | — | — | — |
| Free cash flow | HK$0 | HK$0 | — | HK$0 | — | — | — | — |
| Total assets | — | — | HK$1.82bn | — | HK$1.75bn | HK$1.67bn | HK$1.66bn | HK$1.70bn |
| Cash and short-term investments | — | — | HK$20.2m | — | HK$9.9m | HK$29.9m | HK$6.6m | HK$106.3m |
| Debt | — | — | HK$381.3m | — | HK$346.0m | HK$303.1m | HK$290.1m | HK$297.1m |
| Shareholders' equity | — | — | HK$1.25bn | — | HK$1.22bn | HK$1.20bn | HK$1.22bn | HK$1.25bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -32.7% | -32.7% | -4.4% |
| Net income | 28.7% | -14.6% | 17.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -15.6% | 17.3% | 20.1% | 21.9% |
| Net margin | 80.8% | 38.4% | 31.9% | 30.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 28.4 | 36.3 | 24.7 | 67.8 | 33.3 | 25.3 | -79.8 | 18.1 | 15.2 | 32.5 |
| Price to sales | 29.5 | 23.3 | 7.8 | 10.1 | 7.9 | 8.0 | 7.8 | 6.3 | 17.7 | 17.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 3 years. Last went ex-dividend on 24 Sept 2025.
| FY2025 | FY2024 | FY2023 | FY2017 | FY2013 | FY2012 | FY2011 | FY2010 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.006 | 0.004 | 0.016 | 0.006 | 0.004 | 0.02 | 0.057 | 0.012 |
- 3-for-1 split · 22 Aug 2007
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.